German Chancellor Angela Merkel inaugurates Sanofi plant

28 May 2015

The German Chancellor Angela Merkel has met with Sanofi’s (Euronext: SAN) chief executive and other industry leaders to discuss the status of antibiotic research.

Following the discussion on antibiotics, Chancellor Merkel and Olivier Brandicourt, chief executive of Sanofi, officially inaugurated a new high-tech manufacturing facility that is expected to supply Sanofi’s insulin patients.

Dr Brandicourt said: "Sanofi is very proud that Chancellor Merkel visited our Frankfurt site, which is Sanofi’s largest, integrated site. The Chancellor interacted with research leaders from Sanofi and the Fraunhofer Society to discuss ideas for fueling additional antibiotics research and inaugurated Sanofi’s new, high-tech manufacturing line, which is Sanofi’s global production line for its new insulin therapy for people with diabetes.”

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK